msaABCR operon positively regulates biofilm development by repressing proteases and autolysis in Staphylococcus aureus

FEMS Microbiology Letters
Gyan S SahukhalMohamed O Elasri

Abstract

Staphylococcus aureus is an important human pathogen that causes nosocomial and community-acquired infections. One of the most important aspects of staphylococcal infections is biofilm development within the host, which renders the bacterium resistant to the host's immune response and antimicrobial agents. Biofilm development is very complex and involves several regulators that ensure cell survival on surfaces within the extracellular polymeric matrix. Previously, we identified the msaABCR operon as an additional positive regulator of biofilm formation. In this study, we define the regulatory pathway by which msaABCR controls biofilm formation. We demonstrate that the msaABCR operon is a negative regulator of proteases. The control of protease production mediates the processing of the major autolysin, Atl, and thus regulates the rate of autolysis. In the absence of the msaABCR operon, Atl is processed by proteases at a high rate, leading to increased cell death and a defect in biofilm maturation. We conclude that the msaABCR operon plays a key role in maintaining the balance between autolysis and growth within the staphylococcal biofilm.

References

Oct 1, 1992·Journal of Bacteriology·X WangR K Jayaswal
Mar 5, 1998·JAMA : the Journal of the American Medical Association·B C HeroldR S Daum
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Feb 23, 2002·Science·Cynthia B WhitchurchJohn S Mattick
Jun 24, 2003·Infection and Immunity·Karen E BeenkenMark S Smeltzer
Oct 7, 2004·Applied and Environmental Microbiology·Emmanuelle CharpentierRichard P Novick
Apr 6, 2006·Journal of Bacteriology·Zezhang T WenRobert A Burne
May 19, 2006·International Journal of Antimicrobial Agents·Nagender LedalaRadheshyam K Jayaswal
Jun 1, 2006·FEMS Microbiology Letters·Raja BiswasFriedrich Götz
Apr 13, 2007·International Journal of Antimicrobial Agents·N Z HaqueM J Zervos
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kelly C RiceKenneth W Bayles
Aug 19, 2007·Nature Reviews. Microbiology·Kenneth W Bayles
Apr 26, 2008·PLoS Pathogens·Blaise R Boles, Alexander R Horswill
Dec 3, 2008·Journal of Bacteriology·Nekane MerinoIñigo Lasa
Dec 18, 2008·BMC Microbiology·Karthik SambanthamoorthyMohamed O Elasri
Feb 4, 2009·Infection and Immunity·Katherine J LauderdaleAlexander R Horswill
May 9, 2012·Antimicrobial Agents and Chemotherapy·Aneela Qamar, Dasantila Golemi-Kotra
Jun 27, 2013·Infection and Immunity·Joe M MootzAlexander R Horswill
Aug 24, 2013·The Journal of Biological Chemistry·Chen ChenOlaf Schneewind

❮ Previous
Next ❯

Citations

Jan 20, 2016·Microbiology·Justin L BatteMohamed O Elasri
Feb 1, 2017·Molecular Microbiology·Derek E Moormeier, Kenneth W Bayles
Nov 24, 2017·BMC Microbiology·Gyan S SahukhalMohamed O Elasri
Jun 27, 2018·Journal of Bacteriology·Justin L BatteMohamed O Elasri
Aug 21, 2019·Journal of Bacteriology·Shanti PandeyMohamed O Elasri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.